UBS Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,689,763
Closed -$161M 8584
2018
Q3
$161M Buy
1,689,763
+302,108
+22% +$25.8M 0.06% 278
2018
Q2
$107M Sell
1,387,655
-268,710
-16% -$20.2M 0.05% 385
2018
Q1
$114M Sell
1,656,365
-134,525
-8% -$10.3M 0.05% 349
2017
Q4
$134M Buy
1,790,890
+598,313
+50% +$38.3M 0.05% 337
2017
Q3
$75.5M Sell
1,192,577
-202,060
-14% -$12.6M 0.03% 448
2017
Q2
$89M Buy
1,394,637
+398,236
+40% +$25M 0.05% 382
2017
Q1
$65.7M Sell
996,401
-149,979
-13% -$10.3M 0.04% 454
2016
Q4
$78.9M Sell
1,146,380
-97,495
-8% -$6.99M 0.04% 399
2016
Q3
$87.7M Sell
1,243,875
-128,164
-9% -$9.58M 0.05% 350
2016
Q2
$104M Sell
1,372,039
-160,904
-10% -$11.8M 0.07% 295
2016
Q1
$105M Sell
1,532,943
-337,176
-18% -$24.2M 0.07% 267
2015
Q4
$163M Buy
1,870,119
+14,498
+0.8% +$1.24M 0.11% 205
2015
Q3
$150M Sell
1,855,621
-428,024
-19% -$37.3M 0.11% 207
2015
Q2
$203M Buy
2,283,645
+40,914
+2% +$3.57M 0.14% 177
2015
Q1
$195M Sell
2,242,731
-1,029,154
-31% -$86.3M 0.13% 177
2014
Q4
$277M Buy
+3,271,885
New +$256M 0.19% 121

Other funds holding ESRX

UBS Group's ESRX Position: Q4 2018 in Review

UBS Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 1,689,763 shares — an estimated $161M sold.

UBS Group first reported a position in ESRX in Q4 2014 and held it in 16 quarters. The position peaked at $277M in Q4 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • UBS Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • UBS Group sold 1,689,763 Express Scripts Holding Company shares in Q4 2018, an estimated $161M.
  • UBS Group first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 16 quarters.
  • UBS Group's Express Scripts Holding Company position peaked at $277M in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.